LYTIR

Company · PCSA

Processa Pharmaceuticals, Inc.

Nasdaq's symbol directory lists PCSA on Nasdaq as “Processa Pharmaceuticals, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 10 occasions ($51K); 1 filing by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $51K in total; Insider sales: $0 in total.Jun: Insider purchases $45KJul: Insider purchases $6KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $51KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Russell Skibsted, Chief Financial Officer bought on 2 days latest Jun 30, 2026 bought $12K
  2. George K. Ng, Chief Executive Officer bought on 2 days latest Jul 1, 2026 bought $11K
  3. David Young, Pres. Research & Development bought on 2 days latest Jun 30, 2026 bought $9K
  4. Wendy Guy, Chief Administrative Officer bought on 2 days latest Jun 30, 2026 bought $9K
  5. Patrick Lin, Chief Business - Strategy Off bought on 2 days latest Jun 30, 2026 bought $8K
Every trade (10)
  1. BUYGeorge K. Ng, Chief Executive Officer bought Jul 1, 2026 3,057 shares filing $6K
  2. BUYRussell Skibsted, Chief Financial Officer bought Jun 30, 2026 3,277 shares filing $6K
  3. BUYDavid Young, Pres. Research & Development bought Jun 30, 2026 2,531 shares filing $5K
  4. BUYWendy Guy, Chief Administrative Officer bought Jun 30, 2026 2,436 shares filing $5K
  5. BUYPatrick Lin, Chief Business - Strategy Off bought Jun 30, 2026 2,106 shares filing $4K
  6. BUYRussell Skibsted, Chief Financial Officer bought Jun 15, 2026 2,654 shares filing $6K
  7. BUYGeorge K. Ng, Chief Executive Officer bought Jun 15, 2026 2,465 shares filing $5K
  8. BUYWendy Guy, Chief Administrative Officer bought Jun 15, 2026 2,118 shares filing $5K
  9. BUYDavid Young, Pres. Research & Development bought Jun 15, 2026 2,067 shares filing $5K
  10. BUYPatrick Lin, Chief Business - Strategy Off bought Jun 15, 2026 1,831 shares filing $4K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Soleus Capital Master Fund, L.P. filed Aug 18, 2026 Schedule 13G passive filing 5.8%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Nov 5, 2026
  2. Departure or appointment of directors or officers; Other events filing Nov 4, 2026
  3. Other events filing Oct 29, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.